Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients
Related Experiment Video
Updated: Mar 25, 2026
Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Yann Decker1, Robert Schomburg2, Eszter Németh2
1Department of Neurology, Saarland University, Homburg/Saar, Germany Yann.Decker@uniklinikum-saarland.de.
Background:
Glycosylation alterations have been associated with the development of several human diseases and their animal models, including multiple sclerosis.
Objectives:
We aimed to determine whether immunoglobulin G galactosylation might be changed in multiple sclerosis.
Methods:
Immunoglobulin G was isolated from serum and cerebrospinal fluid of patients with multiple sclerosis or viral meningitis and control patients without history of inflammatory or autoimmune disease. A lectin-based assay was used to investigate potential galactosylation modifications of immunoglobulin G.
Results And Conclusion:
Galactosylation of immunoglobulin G isolated from cerebrospinal fluid of control patients was found to be age- and gender-dependent. In addition, immunoglobulin G galactosylation was significantly altered in cerebrospinal fluid but not in serum of multiple sclerosis patients. Furthermore, this modification was correlated with an active progression of multiple sclerosis. Finally, the loss of galactosyl moieties was not simply associated with inflammation as no such change was detected in viral meningitis patients characterized by brain inflammation.
